The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
Newsletter Jan 2017
Latest Newsletter with the new members of the Scientific Advisory Committee, the public World RePort data base with funding data from NIH, MRC UK, SIDA, EDCTP and other funders and the Ditect-HAT project on diagnostics for sleeping sickness.
Eighth EDCTP Forum
We published the highlights of the Eighth EDCTP Forum in Lusaka, Zambia from 6-9 November 2016
Forum abstracts were published in BMJ Global Health
World TB day 2017: closing the gaps to end tuberculosis
Ending the tuberculosis (TB) epidemic by 2030 is one of the health targets of the Sustainable Development Goals. Although TB…
PredictTB project launched: biomarkers to predict TB treatment duration
A new EDCTP-funded project was launched at the Tygerberg Campus of Stellenbosch University in Cape Town, South Africa, on 16…